News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nanobiotix Appoints Dr. Bernd Muhlenweg as Head of Business Development



2/2/2011 9:16:32 AM

PARIS--(BUSINESS WIRE)--NANOBIOTIX the leading nanomedecine company focused on cancer therapy, announced today that its team has completed a comprehensive executive research and appointed Bernd Mühlenweg, PhD, as Head of Business Development.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES